Cargando…
When could human challenge trials be deployed to combat emerging infectious diseases? Lessons from the case of a Zika virus human challenge trial
Human challenge trials (HCTs) deliberately infect participants in order to test vaccines and treatments in a controlled setting, rather than enrolling individuals with natural exposure to a disease. HCTs are therefore potentially powerful tools to prepare for future outbreaks of emerging infectious...
Autores principales: | Palacios, Ricardo, Shah, Seema K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921433/ https://www.ncbi.nlm.nih.gov/pubmed/31852506 http://dx.doi.org/10.1186/s13063-019-3843-0 |
Ejemplares similares
-
Vaccines, Sera and “New” Viruses: Ebola, Zika and Other Infectious Challenges for Human Health
por: Ciafarone, Alessia, et al.
Publicado: (2017) -
Immunotherapy trials in Parkinson’s disease: challenges
por: Xiao, Bin, et al.
Publicado: (2023) -
Assay Challenges for Emerging Infectious Diseases: The Zika Experience
por: Roberts, Christine C., et al.
Publicado: (2018) -
The challenges of human population ageing
por: Sander, Miriam, et al.
Publicado: (2015) -
Commentary: A transcatheter challenge: Can you deploy a valve into a Big Mac?
por: Guariento, Alvise, et al.
Publicado: (2021)